3,457
Total Claims
$1.3M
Drug Cost
366
Beneficiaries
$3,673
Cost/Patient
Peer Comparison vs. 767 Advanced Heart Failure and Transplant Cardiology providers
-38%
Cost per patient vs peers
$3,673 vs $5,964 avg
+41%
Brand preference vs peers
25.9% vs 18.4% avg
Brand vs Generic
74% generic
Brand: 897 claims · $1.2M
Generic: 2,560 claims · $96K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Tafamidis | 18 | $510K |
| Sacubitril/Valsartan | 287 | $298K |
| Empagliflozin | 260 | $217K |
| Dapagliflozin Propanediol | 81 | $74K |
| Apixaban | 80 | $61K |
| Rivaroxaban | 37 | $42K |
| Sirolimus | 41 | $21K |
| Ivabradine Hcl | 30 | $19K |
| Evolocumab | 12 | $12K |
| Tacrolimus | 72 | $7,238 |
| Alirocumab | 14 | $7,199 |
| Metoprolol Succinate | 267 | $6,390 |
| Potassium Chloride | 108 | $5,872 |
| Torsemide | 147 | $4,966 |
| Eplerenone | 48 | $4,559 |
Prescribing Profile
48
Unique Drugs
$693K
Patient Profile
70
Avg Age
29%
Female
2.49
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About